Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion type Assertion NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_head.
- NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion description "[An in vivo immunotherapy screen of costimulatory molecules identifies Fc-OX40L as a potent reagent for the treatment of established murine gliomas.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_provenance.
- NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion evidence source_evidence_literature NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_provenance.
- NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion SIO_000772 22781551 NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_provenance.
- NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion wasDerivedFrom befree-2016 NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_provenance.
- NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_assertion wasGeneratedBy ECO_0000203 NP996467.RA-GYsDcMGFgTpART4IW7N7tBPfQ16dM4LlY3eQRsBD44130_provenance.